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Abstract
This paper presents the design and fabrication of a multi-layer and multi-chamber microchip
system using thiol-ene ‘click chemistry’ aimed for drug transport studies across tissue bar-
rier models. The fabrication process enables rapid prototyping of multi-layer microfluidic
chips using different thiol-ene polymer mixtures, where porous Teflon membranes for cell
monolayer growth were incorporated by masked sandwiching thiol-ene-based fluid layers.
Electrodes for trans-epithelial electrical resistance (TEER) measurements were incorpo-
rated using low-melting soldering wires in combination with platinum wires, enabling parallel
real-time monitoring of barrier integrity for the eight chambers. Additionally, the translucent
porous Teflon membrane enabled optical monitoring of cell monolayers. The device was
developed and tested with the Caco-2 intestinal model, and compared to the conventional
Transwell system. Cell monolayer differentiation was assessed via in situ immunocyto-
chemistry of tight junction and mucus proteins, P-glycoprotein 1 (P-gp) mediated efflux of
Rhodamine 123, and brush border aminopeptidase activity. Monolayer tightness and rele-
vance for drug delivery research was evaluated through permeability studies of mannitol,
dextran and insulin, alone or in combination with the absorption enhancer tetradecylmalto-
side (TDM). The thiol-ene-based microchip material and electrodes were highly compatible
with cell growth. In fact, Caco-2 cells cultured in the device displayed differentiation, mucus
production, directional transport and aminopeptidase activity within 9–10 days of cell cul-
ture, indicating robust barrier formation at a faster rate than in conventional Transwell
models. The cell monolayer displayed high TEER and tightness towards hydrophilic com-
pounds, whereas co-administration of an absorption enhancer elicited TEER-decrease and
increased permeability similar to the Transwell cultures. The presented cell barrier microde-
vice constitutes a relevant tissue barrier model, enabling transport studies of drugs and
chemicals under real-time optical and functional monitoring in eight parallel chambers,
thereby increasing the throughput compared to previously reported microdevices.
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Introduction
Covering the inner wall of the small intestine is a single layer of epithelial cells that forms a
rate-limiting barrier for the absorption of drugs. Numerous experimental models have been
developed to predict intestinal permeability—including in situ isolated perfused intestinal sys-
tems [1–4]. However, the use of animal models is time consuming, labour intensive and costly.
Furthermore, animal models also raise ethical issues and are often not able to accurately pre-
dict the results in humans [5]. Culturing and differentiation of epithelial cells derived from the
intestine can provide relevant in vitro models for prediction of drug absorption in humans
[6,7]. Caco-2 cells constitute a gold standard of intestinal model when cultured under specific
conditions, i.e., grown on Transwell permeable filter supports, the cells will form a monolayer
[8]. They will further spontaneously differentiate and proliferate, thus exhibiting many features
of the small intestinal villus epithelium [9,10]. Some of the most prominent features of Caco-2
cells cultured in this way are the formation of brush border microvilli [10] on the upper side of
the cells, development of intercellular tight junctions [11], and the presence of various meta-
bolic enzymes present in the intestinal epithelium [10,12]. Due to the formation of a tight
monolayer of Caco-2 cells, this provides a physical and biochemical barrier to the passage of
ions and small molecules through the Caco-2 cell layer. Therefore, it is one of the most well-
established human intestinal epithelial cell lines and has been extensively used as an in vitro
intestinal model for pharmaceutical studies, e.g., ADME-Tox (adsorption, distribution, metab-
olism, excretion, and toxicology) studies. About three weeks are required for Caco-2 cells to
fully differentiate and form confluent and tight monolayers in Transwell inserts [8]. However,
this in vitro model does not incorporate the continuous fluid flow nor the fluid shear stresses
experience by epithelial cells in vivo (reported as 1 to 5 dyn/cm2 [13] depending on location).
By using micro total analysis system technology, various functional microfluidic systems
can be developed to provide integrated microenvironments for cell maintenance, continuous
perfusion and real-time monitoring of cells. Several groups have reported on the design and
fabrication of polydimethylsiloxane (PDMS) based microdevices for Caco-2 cell culture [14–
18]. Kim et al. have reported that with the combination of peristaltic motion and fluid flow in
the microfluidic device, Caco-2 cells displayed intestinal villi-like structures with physiological
growth up to several hundreds of microns in height, as well as increased expression of intes-
tine-specific functions, including mucus production [17]. However, the reported microfluidic
devices are only capable of culturing one set of Caco-2 monolayers for analysis at any one
time. In biological cell analysis studies or drug transport studies across Caco-2 monolayers, or
other model tissue barriers, it is highly desirable to investigate different conditions in the same
experimental system in a high throughput manner [19–22]. Scaling up the number of cell cul-
ture microchambers on the microfluidic chip provides the possibility for analyzing more than
one sample in parallel under controlled conditions, therefore allowing for controlled parame-
ter comparisons. Recently, Trietsch et. al. reported on utilizing the commercial OrganoPlate
platform for culturing 40 membrane-free ‘gut-tubes’ in a 384-well microtiter plate format [23].
In this planar platform, there are two compartments namely the lumen of the ‘gut-tube’ and
the ‘blood-vessel’. These two compartments were separated by an extracellular matrix (ECM)
gel. Although PDMS is an excellent material choice for fabricating microfluidic devices for cell
culture, it may pose some challenges in studies that involve chemicals and drugs. Studies have
shown that PDMS has a tendency to absorb small hydrophobic molecules [24–27] and this
may compromise accurate measurements of drug efficacy and toxicity [26–28]. Alternative
materials such as polymethylmetacrylate (PMMA) [29] and physiologically relevant materials
have been explored and reported for organ-cell culture in microfluidic devices [30].
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To develop an alternative in vitro model of the human intestines for high throughput trans-
port studies (Fig 1), we have explored thiol-ene chemistry and a novel membrane system
within a microfluidic system to develop a multi-chamber microchip. Thiol-ene-based micro-
chips may provide the opportunity for mass production of microchips [31]. Comparisons of
the morphology and essential functions (e.g. tight junction formation, P-gp expression, brush
border enzymatic activity) of Caco-2 cells cultured in the microfluidic device were compared
with Transwell cultures to provide insights on the capability of the microchip materials for
supporting tissue cell culture. To quantitatively evaluate the integrity of the Caco-2 monolayer
in the microfluidic device, two pairs of electrodes that were built in-house, were embedded in
the microchambers to acquire TEER. Fabricating and embedding electrodes in microfluidic
devices [32–35] allowed for a simple, label-free and non-destructive technique for characteriz-
ing the barrier property of epithelial and endothelial cell layers.
Materials and methods
Fabrication of thiol-ene microfluidic device
Two sets of molds were required to fabricate the fluidic layers and electrode grooves of the thiol-
ene microchip. The first mold was fabricated in polymethylmethacrylate (PMMA). The design of
this mold was the exact replica of the thiol-ene microchip design. A second mold made of PDMS
was the inverse design of the PMMA mold. The microchannel designs (200 μm (depth) x 600 μm
(width)) of the top and bottom layers of the microchip were first drawn with an engineering soft-
ware, Autocad (Ver 18.1). Detailed drawings with dimensions of the structures on the different
thiol-ene layers can be found in S1 Fig. To fabricate the first master molds, the drawings were con-
verted to codes by EZ-CAM (ver 15.0, Germany) and micromilled (Mini-Mill/3, Minitech
Machinery Corporation, GA, USA) onto 5 mm PMMA blocks. The second molds were fabricated
by mixing PDMS (DowCorning, Germany) in the ratio of 1:10 (curing agent: pre-polymer),
degassed under vacuum and poured onto the PMMA master mold. The liquid PDMS was cured
in the oven at 70˚C for more than 20 hrs. Once the PDMS molds were cured, they were de-
molded from PMMA molds, bearing the replicated design of the microchip layers.
Pentaerythritol tetrakis-(3-mercaptopropionate) (tetra-thiol moieties), 1,3,5 trilallyl-
1,3,5-triazine-2,4,6(1H,3H,5H)-trione (tri-allyl moieties) and trimethylopropane tris-(2-mer-
captopropionate) (3 thiol moieties) used for fabricating the fluidic layers in the thiol-ene
microfluidic chips were all purchased from Sigma Aldrich, Denmark. The top and bottom
Fig 1. Schematic illustrations of the thiol-ene based microfluidic chip for intestinal transport studies. (A) Cross-sectional view of human intestinal microvilli. (B)
Microarchitecture of one microchamber on the thiol-ene microfluidic chip consisting of upper and lower channel cell culture chambers separated by an ECM coated
Teflon membrane. (C) Co-administration of an absorption enhancer to increase Caco-2 monolayer permeability.
https://doi.org/10.1371/journal.pone.0197101.g001
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layers, containing the fluidic microchannels and chambers were fabricated with a mixture of
tetra-thiol moieties and tri-allyl moieties in stoichiometric ratios. The different components
were mixed, poured onto the PDMS molds and exposed to UV (for 40 s on both sides (Dymax
5000-EC Series UV curing flood lamp, Dymax Corp., Torrington, CT, USA, *40 mW cm−2
at 365 nm) (Fig 2Ai).
Fig 2. Fabrication process of the microfluidic device for Caco-2 culture. (A) Schematic process of fabricating the different layers of the thiol-ene chip (i) process of
fabricating upper and lower fluidic layers; (ii) process of fabricating the thiol-ene coated Teflon membrane. (B) Exploded view of the high throughput multi-layer thiol-
ene microchip for cell culture (Dimension of microchip: 76 mm x 52 mm x 2.7 mm). Thickness of the modified membrane is 0.3 mm. The membrane is coated with a
thiol-ene mixture on both sides to ensure good bonding between the chip layers. Fluids were pumped in the upper and lower layers. (C) SEM images of Teflon
membrane (Top view). Surface morphology was changed significantly after coating a layer of thiol-ene. The surface of the membrane has become very smooth after
coating and curing a layer of thiol-ene (as indicated by red arrow). (D) Expanded view of Teflon membrane that was masked off and rinsed with methanol, maintained
its porous structure in these areas.
https://doi.org/10.1371/journal.pone.0197101.g002
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To fabricate the thiol-ene coated Teflon membrane, a commercially available Teflon mem-
brane (Millipore, Denmark) (0.4 μm in pore size; 40 μm in thickness; porosity ~ 75% accord-
ing to manufacturer’s information) was modified to enable better bonding of the membrane to
the thiol-ene parts containing the fluidic manifolds. A thiol-ene mixture consisting of tri-thiol
moieties and the tri-allyl component as above, in stoichiometric ratios, was prepared and used
to coat the membrane (Fig 2Aii). The coated membrane was exposed to UV radiation for 25 s
through a plastic mask (Infinite Graphics, Singapore) that protected the cell culture regions
(Step 2 in Fig 2Aii). Methanol (Sigma, Denmark) was used to rinse the entire membrane to
remove any uncured thiol-ene (Step 3 in Fig 2Aii). Before bonding the layers, holes for the
inlets, outlets and electrode ports were drilled through the partial cured thiol-ene layers. Thick-
enss of the cured Teflon membrane was measured by a profilometer (Dektak; Brunker). Next,
the layers (thiol-ene coated membrane and thiol-ene fluidic manifolds) were aligned onto each
other by the presence of alignment markers on the microchip layers (Fig 2A and S2 Fig). Slight
pressure was applied with a roller over the layers to ensure good contact between the surfaces.
To finalize the bonding, the combined layers were exposed to UV radiation for an additional
minute on each side (Final step in Fig 2A).
The completed microchip would have two sets of electrodes (top and bottom) embedded
into selected chambers for TEER measurements. The bottom electrodes were positioned at
1.5mm and 3mm from the entrance of the microchamber and top electrodes were positioned at
1.5mm from exit of microchamber (S2 Fig). The bottom electrodes were fabricated using an
Indium alloy (InBiSn (In 51% Bi 32.5% Sn 16.5% by weight); Indium Corp, Utica, NY). Top
electrodes were fabricated using Platinum wire (Pt, Advent, UK) (diameter 0.5 mm). To fabri-
cate the bottom electrodes, the assembled microfluidic chip was first placed onto a hot plate set
at 80˚C for 10 min. Pieces of the InBiSn metal, with length of 5 mm, were inserted into the elec-
trode ports (connecting to the lower fluidic layer) on the thiol-ene microchip. Slight pressure
was applied manually to push the melted metal into the electrode groove. Once the electrodes
were formed, electric wires of diameter 0.4 mm were inserted into the liquid metal to act as con-
necting wires to the multimeter (Keithley, USA). The size of electrodes was about 0.6–0.8 mm
in diameter with a thickness of 0.25–0.3 mm. To fabricate the top electrodes, pieces of Pt wires
(diameter of 0.5 mm, length of 5 mm) were forced fit into the electrode ports drilled through
the top fluidic layer. Two connecting Cu wires were soldered to the Pt wires. To fix the elec-
trodes in position, UV-epoxy (NOA81; Norland, USA) was applied at the junctions between
connecting wires and thiol-ene chip. The entire chip was exposed to UV light for 30 s.
Cell culture
Human Caco-2 intestinal epithelial cells used in the experiments were obtained from Ameri-
can Type Culture Collection ((ATCC), HTB-37, Germany). The passages of the Caco-2 cell
line used in the microfluidics studies ranged from the 40th to 50th passages, and for the Trans-
well studies, passages in the range of 40th to 65th were used. The Caco-2 cells were cultured
routinely in Dulbecco’s Modified Eagle Medium (DMEM; Sigma, Denmark). The culture
medium is supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS; Sigma,
Denmark), 1% (v/v) nonessential amino acids (NEAA; Gibco, Denmark) and 1% (v/v) penicil-
lin-streptomycin (P/S; Gibco, Denmark).
Cell culture in Transwell inserts and microfluidic chip
Transwell system. Control studies were carried out using static cultures of Caco-2 cells in
12-well Transwell plates (Corning, Sigma, Denmark). The inserts in the well plate each con-
tained a porous polycarbonate membrane (1.1 cm2, 0.4 μm pores). In the Transwell studies,
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the Caco-2 cells harvested with trypsin/ETDA solution (0.05%; Sigma, Denmark) were seeded
on the top surface of the porous Transwell membrane at a density of 1 x 105 cells/well. The
Caco-2 cells were grown for 14–16 days in DMEM (Sigma, Denmark) supplemented with 10%
(v/v) FBS, 1% (v/v) NEAA and 1% (v/v) P/S. The medium was changed every second day of
cell culture.
Microfluidic system. After the microchip was fabricated, it was assembled onto the plat-
form with MAINSTREAM components [36]. Briefly, the MAINSTREAM platform consists of
the two peristaltic micropumps (each micropump bearing eight pumplines), cell loading com-
ponents, air pressure network, glass vials acting as the reservoirs for respective inlets and out-
lets, two sets of LEGO Mindstorms (LEGO, Billund, Denmark) controller and motor and the
PMMA platform for placing the microchip and the components (S3 Fig). The Teflon tubings
(inner diameter = 0.2 mm; Bola, Denmark) micro-components and microchip were sterilized
by perfusing 70% ethanol throughout the entire system at a flow rate of 5μl/min for 2 hours.
Following that, sterile water was flushed into the entire system for an additional 2 hours at a
flow rate of 5μl/min. It was crucial to ensure good microenvironment in the cell culture cham-
ber and good cell attachment during cell seeding in the microchip. To achieve this, ECM
known to have the ability in improving the cellular microenvironment [37–39], was used to
coat the Teflon membrane. An ECM mixture of 300 μg/ml Matrigel (Corning, United King-
dom) and 50 μg/ml collagen Type I (BD Bioscience, Denmark) in serum-free DMEM was flo-
wed into the microchip to coat the porous membrane. The ECM mixture was flowed into the
microchip for 2 hours at a flow rate of 5μl/min in an incubator. After the incubation, the
microchip device was perfused with cell culture medium overnight in an incubator (37˚C, 5%
CO2). Following that, the harvested Caco-2 cells from the trypsin/EDTA solution was seeded
into the microfluidic chip.
For cell seeding in the microfluidic microchip, the harvested Caco-2 cells was diluted with
DMEM containing 60% (vol/vol) FBS solution in order to decrease sedimentation. The re-sus-
pended cell mixture was syringed into the ‘cell loading’ reservoirs that were assembled onto
the microfluidic platform. The peristaltic micropump on the microfluidic platform was acti-
vated at a very high flow rate (flow rate 65 μl/min) to draw the cell suspension into the cell
culture chambers. The microchambers were seeded with Caco-2 cells at a concentration of 2.5
x 105 cells/cm2. A normal optical microscope was utilized to observe the distribution of the
cells in the chambers. Caco-2 cells attached onto the ECM-coated Teflon membrane. Next, the
entire system with the microchip was placed in the incubator (37˚C, 5% CO2). After 2 hours,
the peristaltic micropump was activated to perfuse culture medium through the upper micro-
channels and microchambers at a constant flow rate of 0.5 μl/min. Cell culture medium was
flowed only in the upper layer on day 1 of cell culture. This was to ensure the establishment of
an intact monolayer of Caco-2 cells. From the second day of cell culture onwards, the micro-
pump that was perfusing through the lower microchannels and microchambers was also acti-
vated. Flow rate was set at 3 μl/min for both top and bottom channels. Over the 9–10 days of
cell culture, phase contrast images of the cells in four different positions of each of the micro-
chambers were taken and compared.
Cell viability studies with thiol-ene pieces
Live/dead cell staining was conducted using LIVE/DEAD1 Cell Imaging Kit (Life Technolo-
gies Corporation, UK), containing a cell-permeable dye for staining live cells at excitation/
emission 488 nm/515 nm and a cell-impermeable dye for staining dead and dying cells at exci-
tation/emission 570 nm/602 nm. Caco-2 cells were cultured in microchambers of the thiol-ene
microchip for 21 days. To stain the cells, PBS was first flowed across the Caco-2 cells for about
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1hr, followed by incubation with the live/dead dye solution at 37˚C for 1hr. Fluorescent images
of cells were taken using an inverted microscope Zeiss Axio Observer.Z1, Carl Zeiss,
Germany).
The cytotoxicity studies of Caco-2 (seeding concentration of 1 x 104 cells/ml) were analysed
by measuring the metabolic activity of Caco-2 cells cultured in 24-well microplate using Ala-
marBlue1 assay (Life Technologies Corporation, UK). Caco-2 cells were cultured in microwells
with and without cured thiol-ene pieces. To carry out the metabolic studies, Caco-2 cells were
rinsed with PBS and incubated at 37˚C for 2hr with 1.5ml of culture media containing 10% of
AlamarBlue1 solution. Following incubation, 100μl of aliquots were placed into 96-well micro-
plate and analysed with a microplate reader (VICTOR3™ Multilabel Counter model 1420, Perki-
nElmer, USA) at the excitation wavelength of 550 nm and emission wavelength of 590 nm.
Wells containing medium and AlamarBlue1 without cells were used as control sample. Calcu-
lation of metabolic reduction was achieved by subtracting the fluorescence values of control
samples from the samples containing Caco-2 cells (with and without cured thiol-ene pieces).
Trans-epithelial barrier measurements (TEER)
Transwell set-up. TEER was measured in Transwell inserts with Millicell ERS-2 chopstick
Silver/SilverChloride (Ag/AgCl) electrodes (Millipore, USA), and calculated via Eq 1 (see
below).
Microfluidic device. TEER measurements (O) of the Caco-2 cells cultured in the micro-
fluidic device were obtained by coupling the connecting wires of the electrodes to a multimeter
(Keithley, USA) using alligator clips. Each chamber contained two sets of top electrodes and
two sets of bottom electrodes. Each time the TEER values were recorded, only one top elec-
trode and one bottom electrode are connected to the multimeter. Four different configurations
of TEER values were recorded, averaged to calculate the final TEER values measured across
the microchamber.
TEER measurements. The final TEER values (O cm2) were determined by subtracting the
baseline measurement in the absence of cells (Rbaseline) from the read out (R1) and multiplying
with the area of cell culture (Ao, 1.12 cm
2 for Transwell and 0.1 cm2 for the microfluidic
device) as shown in Eq 1.
R1   Rbaseline ¼ TEER ð1Þ
Morphological studies of Caco-2 cells cultured in microfluidic system and
Transwell cultures
Phase contrast images of the Caco-2 monolayers were obtained using an inverted microscope
Zeiss Axio Observer.Z1 microscope equipped with a 10x/0.3 Plan-Neofluar objective, and a
Zeiss Axiocam MRm B/W camera. (Carl Zeiss, Germany). Images were analysed with the
imaging software provided by the microscope manufacturer (AxioVision 4.8.2, Carl Zeiss,
Germany).
Each cell culture chamber was scanned and all images were acquired with a z-stack (6 μm
between each slice) and an exposure time of 5 ms. A specific function in the imaging software,
AxioVision Extended Focus module, was utilized to stitch all individual images and converted
to a single image to obtain the best focused image.
Fluorescent confocal images of the monolayer morphology were obtained using a confocal
microscope (Carl Zeiss, Germany). The procedure for cell staining and the dyes used were the
same for both Transwell cultures and microfluidic device. Between each processing step, the
cells were rinsed with PBS. The Caco-2 cells were fixed with 4% (vol/vol) paraformaldehyde
(Sigma, Denmark) for 30 min, followed by 30 min of permeabilization with 0.1% Triton X-
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100. Next, a blocking buffer (1% bovine serum albumin (BSA; Sigma, Denmark), 0.1% Tween-
20 (Sigma, Denmark) in phosphate buffer saline (PBS; Sigma, Denmark)) was introduced to
the cells for 1 hr. To visualize tight junctions, immunofluorescence staining was performed
using mouse anti-ZO-1 (ZO-1; Life Technologies, Denmark) diluted in the blocking buffer
1:100 and introduced into the cells and left static overnight in the fridge at 4˚C. Immunofluo-
rescence staining was also carried out to stain the mucoprotein, mucin-2. Primary mouse
monoclonal antibody (ab11197; AbCam, Denmark) prepared in blocking buffer (1:100), was
introduced to the cells. The samples were protected from light and left static overnight in the
fridge at 4˚C. Next, the cells were rinsed with PBS, followed by counter-stained with the sec-
ondary antibody (AlexaFluor 488 goat anti-mouse; Life technologies, Denmark) prepared in
blocking buffer (1:200) and left static in room temperature for 2 hrs. Similar immunofluores-
cence staining procedure was carried out to stain the P-gp transporters. Primary rabbit poly-
clonal antibody (ab129450; Abcam, Denmark) prepared in blocking buffer (1:200) was
introduced to the cells and left static overnight in the fridge at 4˚C. Following that, the cells
were rinsed with PBS and stained with secondary antibody (AlexaFluor 488 goat anti-rabbit
IgG H & L; Abcam, Denmark) prepared in blocking buffer (1:200). The cells were left in static
condition in room temperature for 2 hrs. Staining of the nucleus and actin were carried out by
diluting 7-aminoactinomycin D (7-AAD; Invitrogen, Denmark) (32 μM) and Rhodamine
phallodin (RP; Life Technologies, Denmark)) to 1:100 in PBS and incubated with the cells for
1 hr. Lastly, mounting media (Vectashield; VWR, Denmark) was added to the cells to protect
the fluorescent dyes. For the Transwell cultures, the membranes were removed from the
inserts and mounted onto glass slides before microscopic imaging. Staining of cells in the
microfluidic device, were performed in situ within the microchannels by flowing the different
reagents into the microchannels and microchambers via MAINSTREAM platform. Visualisa-
tion of the tight junctions, mucus and P-gp transporters were carried out at excitation/emis-
sion wavelength of 488/570 nm. The stained nuclei were visualised at excitation/emission
wavelengths of 546/647 nm. Fluorescent imaging of the stained Caco-2 cells on the thiol-ene
microchip was performed through the thiol-ene layer on an upright microscope (ZEISS Axio-
scope; Carl Zeiss, Germany). Similar to the phase contrast images, each cell culture chamber
was scanned and all images were acquired with a z-stack (6 μm between each slice). The
recorded images of the cells were analyzed with an imaging process software ImageJ.
Aminopeptidase studies to identify differentiated Caco-2 cells
L-alanine-4-nitroaniline hydrochloride (L-4AN; Sigma, Denmark) was prepared by dissolving
the L-A4N substrate in DMEM without phenol red (DMEM-PR, Gibco, Denmark) to a concen-
tration of 1.5 mM. In the Transwell studies, the Caco-2 cells were first rinsed with DMEM-PR
in both the apical and basolateral sides for 3 times. 500 μl of L-A4N substrate solution was
added to the apical side of the cells and 1500 μl of DMEM-PR was added to the basal lateral side
of the cells and incubated at 37˚C. Sample aliquots of 100 μl was removed from the apical side
at 30 min intervals and transferred to a 96-well microplate. Studies were carried out for a 2 hr
period. Analysis of the sample aliquots were carried out with a microplate reader (Victor 3V;
Perkin Elmer). DMEM-PR was set as the reference. The test was calibrated with a series of dilu-
tions of 4-nitroaniline in DMEM-PR. One unit is defined as the hydrolysis of 1.0 μmol of
4-nitroaniline per minute. All of the reagents preparation and experimental studies were con-
ducted under the protection of light. The aminopeptidase experiments in the Transwell cul-
tures were carried out on in vitro cell culture day 5 and 21.
In the microfluidic device, the aminopeptidase studies were carried out on day 5 of in vitro
cell culture. DMEM-PR was first perfused to both the top and bottom fluidic channels for 45
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min at a flow rate of 3 μl/min. Next, 1.5 mM of L-A4N solution was flowed into the upper
microchannels and microchambers of the thiol-ene microchip at a flow rate of 3 μl/min. Sam-
ple aliquots of 120 μl were removed from the outlets of the upper microchannels at every 30
min and transferred to a 96-well microplate. Similar to the Transwell studies, the sample ali-
quots from the microfluidic system were analyzed for the cleaved product, 4-nitroanalide with
the microplate reader.
Permeability and efflux studies in cell monolayers
The compounds used in the permeability studies, [3H]-mannitol (PerkinElmer; USA), fluores-
cein isothiocyanate (FITC)-labeled dextran (FD4; 4kDa; Sigma, Denmark), insulin (Novo Nor-
disk, Denmark) and tetradecyl-β-D-Maltoside (TDM; Sigma, Denmark) were all prepared
using buffer+ as the diluent. Buffer+ was prepared by mixing Hank’s Buffered Saline solution
(HBSS; Gibco, Denmark), 0.1% (wt/vol) OVA (ovalbumin; from chicken egg white, Sigma,
Denmark) and 10 mM HEPES (HEPES; Sigma, Denmark) at pH 7.4. The different compounds
were prepared in various concentrations: 0.8 μCi/ml [3H]-mannitol, 100 μM insulin (peptide/
drug) or 540 μM FD4, and 0 or 400 μM TDM.
In the Transwell studies, before carrying out the transport experiments, DMEM was
changed to buffer+. 400 μl of buffer+ was added to the apical side and 1 ml to the basolateral
prior to equilibrate the Transwell plate for 60 minutes. Buffer+ was replaced with 400 μl test
solution at the apical side at time zero, and the Transwell plates were incubated at 37˚C and
5% CO2 with gentle shaking. The gentle shaking was to ensure there was little unstirred diffu-
sion layers of fluid in the basolateral region. Basolateral samples were collected every 15 min-
utes for 1 hour and analyzed along with apical test solutions for [3H]-mannitol content in a
scintillation counter (Packard TopCount; PerkinElmer), after mixing with scintillation fluid
(Microscint-40; PerkinElmer), along with a peptide and FD4 content. After the experiments,
the cells were washed twice with buffer+ and replenished with medium for 24 hour recovery.
In the microfluidic system, similar to the Transwell studies, before the start of experiment, the
DMEM was replaced with buffer+. Buffer+ was flowed into the system for 1 hr. Subsequently,
the buffer was changed to the test solutions in the top fluidic layer. Flow rate was set at 3 μl/
min (in both the upper and lower layers). In the collection reservoirs of the basolateral cham-
bers, 200 μl of buffer was added to each of the collection reservoirs. This would enable sample
aliquots of 100 μl collected at every 15 min intervals. Dilution by perfusion was factored in in
the calculation of the permeability of the compounds across the cell monolayers.
Before carrying out the Rh 123 studies, buffer+ was flowed to both the upper and lower
channels for 1 hr. Following that Rh 123 (Sigma-Aldrich, Denmark) prepared in buffer+ to a
concentration of 10 μM was flowed to the basolateral side. 200μl of buffer+ was added to each
waste reservoirs. At each 15min interval, 150 μl was removed from the respective waste reser-
voirs with replacement of 150μl of buffer+. Studies were carried out in triplicates.
Data analysis of permeability results
The Caco-2 translocation of peptide, [3H]mannitol or Rh 123 over Caco-2 layers is expressed
as the apparent permeability (Papp), given by:
Papp ¼
dQ
dt
1
A C0
ð2Þ
Where dQ/dt is the steady-state flux across the cell layer (pmol/s), A is the surface area (1.12
cm2 for Transwell, 0.1 cm2 for microfluidic), and C0 is the initial sample concentration [8].
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The basolateral samples were analyzed for insulin content using commercial insulin
enzyme immunoassay kit (EIA, Phoneix Pharmaceuticals, Germany). Standards were pre-
pared from test solutions, and were fitted to Eq 3 using Prism-6 (GraphPad, Ver 6).
Abs 450nmð Þ ¼ Aþ
B   A
1þ 10ððlogEC50   xÞCÞ
ð3Þ
where x is log(concentration) of peptide in M, and A, B, C and EC50 are fitting parameters
[40].
Basolateral samples were analyzed for FD4 content in a fluorescence plate reader (MD
Spectramax Gemini, USA) with excitation/emission of 490/525 nm, based on standard curves
prepared from test solutions. Statistical analysis was carried out using the software Prism-6,
where unpaired Students t-tests were used for comparison, and a significant difference was
considered if p< 0.05. Results are presented as the mean ± standard deviation of the mean
(SEM).
For the P-gp studies, the collected samples were analyzed for Rh 123 content using a fluo-
rescence plate reader with excitation/emission of 485/546nm, based on standard curves pre-
pared from test solutions. The efflux ratio of P-gp was determined by:
efflux ratio ¼
Papp ðBasal!ApicalÞ
Papp ðApical!BasalÞ
ð4Þ
Similar to the permeability studies, all P-gp results were calculated as mean ± standard
error (SEM). Statistical evaluation of the quantified data was carried out using the software,
Prism-6. A significant difference was considered when p< 0.05.
Results and discussion
Development of thiol-ene-based microchip for Caco-2 cell culture
We designed and developed a thiol-ene based microchip that consists of eight cell culture
micro-chambers where each cell culture chamber has two compartments (to become the apical
and basal side of the cell layer, respectively) (Fig 1). The developed microchip contains eight
micro-chambers, thus allowing parallel culturing of Caco-2 cells or other tissue models (Fig
2B). The design of eight channels allows for significant controls during drug transport studies
and allowed us to employ the previously reported microfluidic flow system developed by oth-
ers [36]. Thiol-ene was chosen since thiol-ene polymers have been reported to have low vol-
ume shrinkage [41,42] and are biocompatible for use in cell culture [43]. Additionally, thiol-
ene polymers have a low affinity to absorb molecules [41,42,44]. For instance, an earlier study
showed that when Rhodamine B was incubated in microchannels fabricated from thiol-ene
polymers and PDMS, respectively, increased fluorescence was observed on the outside of the
PDMS channels as compared to the thiol-ene channels [44]. The thiol-ene-based microchip
has an external dimension of 76 mm x 52 mm x 2.7 mm and consists of three layers. The
detailed dimensions of the structures on the different chip layers are shown in S1 Fig. The top
and bottom layers of the microchip were fabricated via the method reported by Lafleur et. al.
[45] using a two-step UV exposure [46,47]. In this method, curing of the thiol-ene polymers
was carried out without a photoinitiator present; it should be noted that this will typically not
lead to curing with regular UV-light sources [41,42,45–48]. Extra care was taken during the
UV-light exposure of thiol-ene polymers to avoid complete curing of stoichiometric thiol-ene
[46], since this will prevent strong bond formation between the different thiol-ene layers dur-
ing the bonding step.
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The porous Teflon membrane—sandwiched between the thiol-ene fluidic layers—became
transparent to visible light when wetted (S4 Fig), thus allowing real-time and fluorescence
microscopic monitoring of the Caco-2 cells cultured on it. The bonding of the thiol-ene top
and bottom fluidic layers with the Teflon membrane required a dedicated modification of the
membrane. The porous Teflon membrane was coated with a thiol-ene mixture and exposed to
UV radiation with a plastic mask that protected the part of the membrane to be used for cell
cultures. Methanol was used to rinse the entire membrane to remove any traces of uncured
thiol-ene. The end result was a thiol-ene modified membrane with regions, which were not
coated with thiol-ene and thus allowed the porous Teflon membrane to be used for cell cultur-
ing (S3 Fig). Thickness of the regions that were not coated with thiol-ene remained as 40μm,
while regions that were coated with cured thiol-ene was 300μm in thickness. When examined
with a scanning electron microscope (SEM), a smooth surface was observed in regions where
the porous Teflon membrane was coated with thiol-ene and exposed to UV light (Fig 2C). In
regions that were masked and rinsed with methanol, the porous structure of the Teflon mem-
brane was preserved (Fig 2D). This procedure clearly demonstrated that thiol-ene ‘click’ chem-
istry can be exploited to functionalize and pattern the membrane surface [46,47]. In the
pressure burst studies of the microfluidic chip (S5 Fig), the multi-layer microchip could with-
stand burst pressures of more than 6 bars (S1 Table). The presented method of fabricating the
microfluidic chip can easily be carried out at room temperature and in standard laboratory
environments, therefore eliminating the need for costly or specialized cleanroom facilities.
Biocompatibility of the thiol-ene material
Caco-2 cells were cultured with and without pieces of cured thiol-ene material in microtiter
plate wells. The metabolic activity was assessed using AlamarBlue1 assay for selected days
during the culture (Fig 3A). The percentage reduction of AlamarBlue1 for cell cultures with
thiol-ene pieces were comparable to microwells with no thiol-ene pieces, indicating that the
thiol-ene had no adverse effect on the metabolic activity. The metabolic activity of the Caco-2
cells increased steadily from days 0 to 21 of in vitro culture. For both control cultures and cul-
tures in the presence of thiol-ene pieces, the rate of metabolic activity of Caco-2 cells were
higher between day 0 to 5 of in vitro culture compared to day 5 to 10 and day 10 to 21 respec-
tively. The metabolic activity is likely related to the proliferation of Caco-2 cells. In the litera-
ture, it was shown that proliferation of Caco-2 cells takes place after 48hr of seeding the cells
and proliferation rate of Caco-2 is most rapid between day 3 to day 9 of cell culture [10,49],
Fig 3. Biocompatibility of thiol-ene. (A) Metabolic activity of Caco-2 cells (AlamarBlue1 assay) over day 0 to day 21 of in vitro cell culture. (n = 3; mean ± SEM; scale
bar = 50μm) (B) Microscopic images of Caco-2 cells cultured in thiol-ene microchip (i) Phase contrast image of Caco-2 cells cultured on day 1 of in vitro cell culture; (ii)
Day 11 of in vitro cell culture; (iii) live/dead cell staining of Caco-2 cells on day 11 of in vitro cell culture.
https://doi.org/10.1371/journal.pone.0197101.g003
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which is consistent with our results. At day 21, the metabolic rate is not much higher than at
day 10 which may indicate that once the proliferation has stopped (around day 10), the meta-
bolic activity showed only modest increment during differentiation. An earlier study showed
comparable biocompatibility of three different cell lines cultured on standard cell substrates
and thiol-ene material [50]. This further emphasized the biocompatibility of thiol-ene as a suit-
able cell culture material.
The culture condition on chip under perfusion is however very different compared to batch
cultures for assessing biocompatibility. Caco-2 cells were seeded on the chip and cultured
under flow condition. Phase contrast images of the Caco-2 cells cultured in the thiol-ene
microchip were taken after seeding and over the days of culture. Cells adhered well on ECM
modified membrane (S6 Fig) and less well on unmodified membrane (S7 Fig). ECM seem crit-
ical, as very few cells were observed on unmodified membrane after 5 days of cell culture
under perfusion (Compare figures S7B Fig, Fig 3B and Fig 4). The apparent dependence on
ECM for culturing Caco-2 cells is supported extensively in the literature [37–39,51–54]. At day
1 of in vitro cell culture (after 24hr of continuous perfusion of cell culture media across the
cells), at least 80% of all the microchambers showed Caco-2 coverage (Fig 3Bi). From day 1 to
day 11 of in vitro cell culture, Caco-2 cells in the microchambers were observed to proliferate
and differentiation of cells took place at day 6 of in vitro culture (results not shown). At day 11
of in vitro cell culture, ‘dark patches’ (indicated by red arrows in Fig 3Bii) were observed on
the cells. At day 11 of in vitro cell culture, the live/dead staining showed that > 95% of the
Caco-2 cells cultured in all the microchambers on the thiol-ene microchip were alive (Fig
3Biii) indicating excellent biocompatibility of the thiol-ene material.
Characterization of Caco-2 cell growth pattern under flow conditions
The characterization of Caco-2 growth pattern was under the following conditions: cell culture
medium was perfused through the upper and lower fluidic layers at a flow rate of 3 μl/min for
9–10 days of in vitro cell culture. A flow rate of 3 μl/min corresponds to a dynamic shear stress
of 0.008 dyn/cm2, which falls within the range of what cells experience in the human intestines
[55,56]. Caco-2 cells were observed to adhere onto the ECM coated Teflon membrane within
30 min after cell seeding. During the phase of active growth, it was observed that once the flow
of cell culture media was started (first 24 hrs of cell culture), the Caco-2 cells spread out [57],
although, in some regions the cells grew in clusters (Fig 4A). It was also observed that flowing
DMEM at 0.5μl/ml for the first 16-24hrs across the cells, was sufficient to wash-out the unat-
tached Caco-2 cells (S6B Fig) without releasing the cells. By day 2 (Fig 4B), the cells had dis-
tinct polygonal shapes with clear, sharp boundaries between the cells. The shape and
morphology of the Caco-2 cells in the microfluidic device were similar to the cells cultured in a
microplate (results not shown). Confluent monolayers of Caco-2 cells were observed in the
microfluidic device typically around day 3–5 of cell culture. From day 5, it was apparent that
cells grew on top of each other suggesting the formation of folds (4B and C) and it became
more challenging to observe the cells through an optical microscope (Fig 4C). It is unclear if
the folds indicate the formation of villi structures. From day 7 onwards, the appearance of
‘dark’ patches (Fig 4D) were observed on the cells.
The establishment of apical tight junctions determines the integrity of the human intestinal
epithelial cell monolayer [8]. To visualize and validate the presence of apical tight junctions in
the Caco-2 cells cultured in the microfluidic device, immunofluorescence staining using anti-
bodies directed at the tight-junction protein, ZO-1, was carried out.
The immunofluorescence images confirmed the formation of confluent Caco-2 monolay-
ers, expressing tight junctions (Fig 4E and 4F). Analysis of the vertical sections of the confocal
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images of the Caco-2 cells (Fig 4G) revealed that the tight-junction proteins were situated
between neighbouring cells at the apical side of the Caco-2 cells (Fig 4E and 4G). Images of the
cells cultured in the Transwell inserts at day 21 appeared cuboidal with a measured heights of
14–20 μm (Fig 4H). However, the Caco-2 cells cultured in the thiol-ene microfluidic device
(three days of cell culture) were observed to appear columnar in shape with heights of 40–
50 μm according to measurements with confocal microscopy (Fig 4G). The Caco-2 cell layer
grew in height after prolonged culture (Fig 4G) while corresponding Transwell plates cultures
remained thin (Fig 4H). It is unclear if the growth in height is due to Caco-2 cells growing on
top of each other or if the cells are elongated. The Caco-2 cells cultured in our microfluidic
device is about the same columnar size and shape (40–50 μm) as reported in healthy human
intestinal epithelial cells [58]. We can confirm previous results indicating that perfusion [17]
seem to stimulate the Caco-2 cells to polarise into columnar cells that were almost 2 fold taller
than the cells from Transwell inserts.
In the reported microfluidic device, as the cell culture period progressed in the microfluidic
device, from microscopic phase contrast images, there were observable regions of ‘dark’
patches (Fig 4D, S8 Fig). These ‘dark’ patches started appearing from day 7 of cell culture but
became more prominent from day 8 onwards. We observed that these dark patches were
Fig 4. Morphology of Caco-2 cells cultured in the microfluidic device. Caco-2 cells cultured in microfluidic system (A-G). Caco-2 cells cultured in Transwell system
(H-I). Phase contrast images of the Caco-2 cells cultured in the microchambers on the thiol-ene microchip over 10 days. (A) Day 1; (B) Day 2; (C) Day 5; (D) Day 8.
Cells multiply and differentiate over the days of culture. Folds in the monolayer of Caco-2 cells start appearing from day 4 of cell culture. The folds in the Caco-2
monolayers are more prominent from day 5 onwards (indicated by red arrows). Dark ‘patches’ also start appearing on the Caco-2 monolayers from day 7 onwards. They
become more prominent from day 8 of cell culture (indicated by blue arrow). (E) Immunostaining of zonula occludens-1 (ZO-1) (green) and nuclei (magenta) for Caco-
2 cells cultured in microfluidic device. (F) Caco-2 cells cultured in Transwell stained for nucleus and ZO-1 (Nuclei in red and ZO-1 in green) (Day 21). (G) Vertical
cross-section view of the Caco-2 monolayer (nuclei in magenta, ZO-1 in green). The Caco-2 cells are 40 μm– 50 μm in height on day 3 of cell culture in the thiol-ene
microfluidic chip. (H) Vertical confocal image of Caco-2 cells in Transwell (Nuclei in red and tight junctions in green). Immunofluorescence staining of nucleus and
mucus on Caco-2 cells cultured in: (I) Thiol-ene microchip on day 10 of cell culture (nucleus in red, mucoprotein 2 (MUC-2) in green). The fluorescent images of the
cells demonstrate that the cells have polarised into columnar cells of about 100 μm in height and formed villous-like structures. (J) Cells in the Transwell inserts were
stained for nucleus and mucoprotein 2 at day 21. Only the nuclei could be fluorescently imaged but not MUC-2. Height of cells were about 25–30 μm at day 21. Cells
were photographed at 10 x magnification. (Scale bar = 50 μm) (K) Differentiation of Caco-2 cells cultured in Transwell inserts and thiol-ene microchip as indicated by
the activity of the brush border enzyme aminopeptidase. (n = 3, mean ± SEM;  p< 0.03,  p< 0.001,  p< 0.0001).
https://doi.org/10.1371/journal.pone.0197101.g004
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absent when the cells were cultured at a low flow rate of 0.5 μl/min (results not shown). To fur-
ther investigate the nature or origin of these ‘dark’ patches, the Caco-2 monolayers were
stained for the muco-protein, Mucin-2 (Mucin-2 is commonly found in human intestines) on
day 10 of cell culture. Immunofluorescence staining directed towards the protein Mucin-2
showed positive stains at the apical surfaces of the villous Caco-2 monolayers (Fig 4I). Mucus
production was not observed in static Transwell cultures (Fig 4J) corroborating previous find-
ings [19], but has previously been reported for microfluidic devices [14,17,59]. The mucus pro-
duction may stem from the gastrointestinal tract’s defence mechanism towards mechanical
stress [60–62]. Although Caco-2 may have derived from an adenocarcinoma, under desirable
conditions (e.g. stromal factors [63], mechanical cues [17,59]), Caco-2 cells may lose control in
differentiating to exhibit capabilities and morphologies that are otherwise not commonly seen.
For example, a study reported on embedding Caco-2 cells into a collagen matrix and culturing
them in vivo, resulted in cells expressing either mucous, enteroendocrine, Paneth or absorptive
cell markers [63]. Thus, suggesting that Caco-2 cells may contain different lineage progenitors
or they are multipotential. Previous reports have linked the mucus production to higher fluid
flow and cyclic peristaltic motions [14,17,59]. Although the fluidic shear is lower here ( 0.008
dyn/cm2 at 3μl/min), it appears to cause production of Mucin-2, whereas Transwell cultures
did not show the presence of Mucin-2 on the Caco-2 monolayers (Fig 4J).
Differentiated Caco-2 cells express intestinal brush border enzymes [10,12], so to further
evaluate the differentiation of microchip Caco-2 cells compared to Transwell cultures, we mea-
sured the level of aminopeptidase activity via conversion of the substrate L-alanine-4-nitroani-
line hydrochloride (L-A4N). Both systems were tested on day 5 of culture, whereas Transwell
monolayers were additionally tested on day 21. In Transwell cultures aminopeptidase activity
increased by more than 5-fold between day 5 and day 21, consistent with earlier findings
[12,17]. In microfluidic device cultures, at day 5, the aminopeptidase activity was higher than
in the Transwell cultures at day 21 (Fig 4K), consistent with earlier findings in microfluidic
devices [14,17]. These results indicated that Caco-2 cells cultured in the presence of continu-
ous flow required a shorter time to polarize and differentiate.
Barrier functions
TEER is a widely used technique for measuring epithelial cell monolayer tightness and integ-
rity. To approach an equal potential drop over the entire membrane [64], the electrodes in the
microfluidic device were embedded directly above and below the membrane. A low-melting
indium alloy (InBiSn) was used for the bottom electrodes and platinum wires for the top elec-
trodes. TEER measurements were obtained by coupling the electrodes to a multi-meter (Keith-
ley, USA) that supplied DC signals (constant current = 10 μA). Dissimilar materials were
chosen for fabricating the electrodes due to the properties of the metals. InBiSn is a very soft
and brittle (Brinell hardness = 11 HB [65]) metal. To place the InBiSn metal as top electrodes
this will require heating of the microchip to soften the microchip layers to insert the InBiSn
metal. Hence, melted metal may drip onto the porous membrane in the microchamber. Alter-
natively, by force-fitting the metal into the electrode ports, would have resulted in breakage of
the metal. Due to these challenges, platinum was chosen for the top electrodes. TEER measure-
ments of the Caco-2 monolayer cultured in the thiol-ene microchip were taken from day 3
onwards of cell culture and monitored over the remaining days of the experiments. Impor-
tantly, the TEER measurements of the Caco-2 cells cultured in the thiol-ene microchip and the
transwell plates showed a significant increase over the first days of recording (Fig 5A). Both
culture systems reached a plateau phase in terms of TEER. The TEER values from the pre-
sented microfluidic device displayed larger variation compared to the Transwell setup with
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commercial TEER measurement equipment, which may be due slight differences in electrode
design and position in the 8 microchambers [66], and may be optimized in future device
generations.
To validate the accuracy and dynamic span of TEER values acquired from the electrodes on
the microfluidic chip, a permeation enhancer, tetradecyl-β-D-maltoside (TDM) [67–69], was
introduced to the Caco-2 monolayers for two hours. The concentration of TDM used in the
earlier reported studies is expected to cause a transient disruption of the Caco-2 monolayer
integrity, while causing minimal cell death [67,68], which is reversible after 24 hours in fresh
cell culture medium. In the presence of TDM, the TEER values measured in the microfluidic
device dropped to 21% of their initial values, and recovered to 90% after 24 hours of continu-
ous perfusion with cell culture medium, consistent with results from static Transwell cultures
(Fig 5B). This indicates that the electrodes fabricated on the microfluidic device were sensitive
to detect dynamic changes in the integrity of Caco-2 monolayers.
Another important characteristic present in differentiated Caco-2 cells is the presence of
efflux transporter P-gp. These P-gp transporters play an important role in determining the bio-
availability of drugs, especially the orally administered drugs. We evaluated the presence of P-
gp transporters in the Caco-2 monolayers cultured in the microfluidic system by carrying out
permeability studies with a well characterized substrate, Rh 123 (as a model drug for uptake
and transport) on day 10 of cell culture (Fig 5C). Rh 123 was flowed through either the apical
or basal compartments and sample aliquots were collected accordingly from the basal or
apical collection reservoirs. The apparent permeability in the apical-to-basal direction was Papp
(apical! basal) 1.03 x 10
−6 cm/s. However, Papp(basal! apical) 1.12 x 10
−5 cm/s, suggesting
that Rh 123 was transported across the Caco-2 monolayer by the P-gp transporters in the basal
to apical direction. The resulting efflux ratio 10.8 was comparable to previously reported val-
ues for static Transwell cultures [70–72]. An efflux ratio of higher than 2 is a strong indicator
that P-gp transporters are present in the Caco-2 cells [73]. To further confirm the presence of
P-gp transporters in the Caco-2 monolayers, immunofluorescence staining towards the P-gp
transporters was performed (Fig 5D).
Permeability studies of FITC–dextran (FD-4), mannitol and insulin in the
presence or absence of permeability enhancer
To further assess the rate-limiting barrier of the Caco-2 monolayers cultured in the thiol-ene
microchip, the behaviour of three different test compounds (mannitol, fluorescein isothiocya-
nate (FITC)-labelled-dextran (FD4) and insulin) was studied (Fig 6A). Mannitol and dextran
were used as model drugs. Insulin was used due to the interest in oral delivery of this drug in
the pharmaceutical industry to provide a proof of concept of the Caco-2 monolayers cultured
in the thiol-ene microchip for drug permeability studies. Insulin is usually administered by the
subcutaneous route [74,75]; however, orally delivered insulin is attracting considerable atten-
tion due to the improved compliance this would provide for diabetic patients [74]. Oral deliv-
ery of insulin has major limitations, due to the degradation of insulin by proteolytic enzymes
in the gastrointestinal tract and poor intestinal barrier permeability due to its molecular weight
[75]. The oral bioavailability of insulin can be improved by e.g. co-administration of perme-
ability enhancers [67–69,76,77].
The permeabilities (Papp) for mannitol, FD-4 and insulin were slightly higher (not signifi-
cant) in the microfluidic chip system at day 9 or 10 of cell culture, compared to the static
Transwell cultures at day 14 of in vitro cell culture (Fig 6B). To further investigate whether the
permeability of different test compounds was affected by the introduction of the permeability
enhancer TDM, Caco-2 monolayers in microfluidic device or Transwell inserts were exposed
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to mixtures of test compounds with and without TDM (Fig 6A). In both systems, the Papp val-
ues for all three compounds greatly increased in the presence of TDM, with significant differ-
ences (p< 0.0001) between the pre- and post TDM studies for both cell culture systems (Fig
6B). The results demonstrated that the addition of TDM permeabilized the Caco-2 monolayers
in both systems and allowed substantial transport of compounds across the Caco-2 monolay-
ers. Additionally, the Papp values of the test compounds in the presence of TDM were compa-
rable between the static Transwell cultures and the microfluidic system (p< 0.0001 for
mannitol and insulin studies but p < 0.02 for FD4 studies). In both systems TEER was
Fig 5. Barrier functions of Caco-2 cell monolayers in the microfluidic device or Transwell system. (A) TEER measurements of Caco-2 cells cultured in thiol-ene
microchip and Transwell inserts for the same cell concentration of 2.55 x 105 cells/cm2. (Here, number of measurements per data point n = 12 for microfluidic device;
and n = 5 for Transwell inserts). (B) Effect of test compounds alone or with TDM on Caco-2 TEER in the Transwell or microfluidic system, immediately after the
experiment or following 24 h recovery in medium. (C) Rh 123 accumulation profile in the basolateral and apical chambers across Caco-2 monolayers in microfluidic
device. Data points represent mean ± SEM (n = 3). Where ns = not significant and  p< 0.001. (D) Immunofluorescence staining of P-gp on Caco-2 cells cultured in
microfluidic device (nucleus in magenta, P-gp in cyan). Magnification 20x; scale bar = 50 μm.
https://doi.org/10.1371/journal.pone.0197101.g005
A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies
PLOS ONE | https://doi.org/10.1371/journal.pone.0197101 May 10, 2018 16 / 23
reversibly decreased following TDM addition, recovering to normal levels within 24h in fresh
medium (Fig 5B). The continuous flow of culture media across the cells in the microfluidic
device may have aided the recovery of barrier property, although to our knowledge, the time-
course of Caco-2 monolayer recovery following absorption enhancer challenge in microfluidic
devices has not previously been reported. This phenomenon observed in the Caco-2 monolay-
ers cultured in the microfluidic device further strengthen the potential of such in vitro plat-
forms for ADME-Tox studies.
Conclusion
A thiol-ene based multi-chamber and multi-layer microfluidic chip was engineered to provide
a controlled platform to sustain long-term Caco-2 cell cultures under fluidic flow for transport
studies. Characterization of the microfluidic chip revealed that the functionality of the porous
Teflon membrane (sandwiched between the top and bottom fluidic layers) could be changed
by coating and curing it with a thiol-ene mixture, followed by ECM coating of the porous
region of the Teflon. Thus, bonding the Teflon membrane between two cured thiol-ene layers
within a fluidic system formed a microchip that could support long time cell culture. Growth
and differentiation of Caco-2 cells cultured in the thiol-ene microfluidic chip accelerated
under continuous flow conditions. The Caco-2 cell monolayers formed a tight barrier with P-
gp transporters and mucus production, effectively mimicking the human intestine and serving
as a functional drug transport model. The performance in terms of barrier function of the
Fig 6. Permeability studies of Caco-2 layers with different compounds. (A) Schematic drawing of membrane enhancer and drugs flowed across the Caco-2 cells
cultured in the microfluidic device. Insert is an enlarged schematic view of disrupted tight junctions upon co-administering the membrane enhancer TDM. (B)
Comparison of permeability profiles of different compounds with or without TDM experimented on Caco-2 layers cultured in microfluidic device versus Transwell: (i)
mannitol, (ii) FD4 and (iii) insulin. Data points represent mean ± SEM (n = 4; p 0.02,  p< 0.0001 and ns = not significant).
https://doi.org/10.1371/journal.pone.0197101.g006
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chips was very similar to Transwell plates. The described chip may therefore be a suitable brick
in a human-on-a-chip concept.
Supporting information
S1 Fig. Cad drawings of the different layers in the thiol-ene microchip.
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S2 Fig. Schematic overview of thiol-ene microchip with electrode ports and alignment
markers. (A) Schematic drawing of the microfluidic layers stacked together. (B) Enlarged view
of the microchamber with the electrode ports.
(DOCX)
S3 Fig. Assembled thiol-ene microfluidic chip with the cell culture platform. Blue arrow
indicating the micropump perfusing through the top layer. Red arrow indicating the peristaltic
micropump perfusing through the bottom layer. (Scale bar = 5 cm).
(DOCX)
S4 Fig. Porous Teflon membrane modified with a layer of cured thiol-ene mixture. (A)
During UV-exposure, regions on porous membrane that was protected by a plastic mask.
These regions are indicated by the black arrow. When dry, the region appeared white and
opaque. (B) Two chambers were wetted with DI water, as indicated by red arrows. Teflon
membrane becomes transparent in visible light. (Scale bar = 5 mm).
(DOCX)
S5 Fig. Burst pressure study for thiol-ene microchip. (a) Schematic view of the pressure sys-
tem [48]. The thiol-ene microchip was clamped between the PC holders. The pressure sensor
on the top of the PC holder will measure the pressure of the set-up. The syringes are com-
pressed to provide the pressure into the microchip. (b) Microfluidic chip filled with red dye.
The inlet and outlet ports for the bottom fluidic layer and outlet for the top layer were sealed
with cured thiol-ene. The inlet port of the top fluidic layer is clamped between the mechanical
device. (scale bar = 5mm).
(DOCX)
S6 Fig. Phase contrast microscopic images of Caco-2 cells seeded in microchambers. (A)
2hrs after seeding before starting the continuous flow of DMEM across the cells; (B) 16hr after
starting flow of DMEM across the cells. Images were taken at the same position of the same
microchamber. (scale bar = 100μm).
(DOCX)
S7 Fig. Phase contrast images of Caco-2 cells cultured in microchamber that was not func-
tionalized with ECM. Images were taken at the same position of the microchamber. (A)
Images of Caco-2 cells captured after 6hr of cell seeding; (B) Images of Caco-2 cells captured
after 5 days of continuous perfusion. (Scale bar = 50μm).
(DOCX)
S8 Fig. Overview of the entire microchamber of Caco-2 cells at day 8 of in vitro cell culture.
Caco-2 cells showed very observable dark patches at regions close to the inlet of the micro-
chamber (indicated by red arrows). Caco-2 cells displayed villous-like structures. (scale
bar = 50 μm).
(DOCX)
S1 Table. Tabulated data of the maximum pressure the different thiol-ene mixtures used
for fabricating the microchips could withstand in different temperature conditions. All
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thiol-ene mixtures were prepared in stoichiometric ratios. Where 4T = tetra-thiol, 3T = tri-
thiol and 3E = tri-allyl. (n = 6).
(DOCX)
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